• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Sophia Agelaki, Maria Spiliotaki, +4 authors Christos Stournaras
  • Biology, Medicine
  • Cancer biology & therapy
  • 2009 (First Publication: 1 August 2009)
  • Caveolin-1, an essential protein constituent of caveolae, is involved in cell signalling through its association with various signalling molecules. Epidermal growth factor receptor (EGFR) interactsExpand
  • Maria Spiliotaki, Dimitris Mavroudis, +6 authors Sofia Agelaki
  • Medicine
  • Breast Cancer Research
  • 2014 (First Publication: 29 November 2014)
  • IntroductionClinical dormancy is frequently observed in breast cancer. In the present study, we aimed to characterize circulating tumor cells (CTCs) in dormancy candidates (DC) with early breastExpand
  • Maria Spiliotaki, Haris Markomanolaki, Marilena Mela, Dimitris Mavroudis, Vassilis Georgoulias, Sofia Agelaki
  • Medicine
  • Lung cancer
  • 2011 (First Publication: 1 August 2011)
  • The effects of AVE1642, a human monoclonal antibody against IGF-IR, were examined in NSCLC cell lines in order to characterize its anti-proliferative and anti-angiogenic activity as a single agentExpand
  • Maria Spiliotaki, Harris Markomanolaki, +4 authors Sofia Agelaki
  • Medicine
  • 2012 (First Publication: 15 April 2012)
  • Background: In breast cancer (BC) recurrences frequently occur many years after removal of the primary tumor. These relapses are thought to originate from cells that disseminated from the primaryExpand
  • Maria Spiliotaki, Dimitris Mavroudis, +6 authors Sofia Agelaki
  • Biology, Medicine
  • Molecular oncology
  • 2018 (First Publication: 16 November 2017)
  • In patients with breast cancer, markers of aggressiveness such as dysregulation of the insulin‐like growth factor receptor (IGF1R) system and E‐cadherin loss are commonly observed. Reduced IGF1RExpand
  • Sophia Agelaki, Dimitrios Mavroudis, +4 authors Vasilis Georgoulias
  • Medicine
  • 2013 (First Publication: 15 December 2013)
  • Background: CTCs have significant prognostic role in patients with breast cancer. Several techniques developed for CTC detection might help in monitoring treatment efficacy. The CellSearch System isExpand